New study tests better insulin dosing for kids with diabetes

NCT ID NCT04124302

Completed Disease control Sponsor: Medical University of Warsaw Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 76 children with type 1 diabetes to see if a different way of calculating insulin doses before meals could improve blood sugar control. The children used their usual rapid-acting insulin (glulisine, aspart, or lispro) via a pump. The goal was to find which method leads to fewer blood sugar spikes after eating.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Insulin (glulisine, aspart, or lispro)
What this could lead to: If successful, this could help children with type 1 diabetes better manage their blood sugar after meals, reducing highs and lows.
What could go wrong: This is a small, completed study comparing existing insulin types and dosing methods. It does not test a new treatment, so any improvements may be modest and not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 1 diabetes mellitus 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 1

Contacts and locations

Locations

Warsaw Medical University

Warsaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.